baber/WOPTO huggingface dataset:
Patent AU-5542898-A (AU)
Title: Data interfacing device
Inventor: HOOGENBEMT STEFAAN MARGRIET AL
IPC: H04Q11/04
Filed: 1998-02-23
Abstract: An interfacing device (INT) which replaces M outgoing sets of bits out of N outgoing sets of bits (OS1, OS2, ..., OSN) by M incoming sets of bits (IS1, IS2, ..., ISM), M being smaller than N, includes :     a. an outgoing register (OR) wherein the N outgoing sets of bits (OS1, OS2, ..., OSN) are temporarily stored; and b. a selector (SEL) comprising a multiplexer bank (MUX) with N multiplexers (MUX1, MUX2, ..., MUXN) each having one output at most M inputs whereto at most M incoming sets of bits are applied, and a control unit (CTRL) for the multiplexer bank (MUX). The control unit (CTRL) can control the multiplexers (MUX1, MUX2, ..., MUXN) so that an appropriate order is respected by the outgoing sets of bits (OS1, OS2, ..., OSN).   <IMAGE>
Patent AU-5681100-A (AU)
Title: Method for producing 4,6-dichloropyrimidine
Inventor: MAIS FRANZ-JOSEF
IPC: C07D239/30
Filed: 2000-06-13
Abstract: The present invention relates to a process for preparing 4,6-dichloropyrimidine by reaction of 4-chloro-6-hydroxypyrimidine with an acid chloride.
Patent AU-5697494-A (AU)
Title: Inside lining for edge plates
Inventor: HITZBLECK SIEGFRIED
IPC: E05B15/02
Filed: 1993-12-07
Abstract: A plastic inside lining is disclosed for edge plates (5) which are inserted into form-fitted depressions (3) drilled into door frames (2) or the like in such a way that they end in a curve. In order to obtain a version which is particularly easy to fit, an intermediate layer (Z) similar to a decorative strip is provided between the visible edges (a) of the edge plate (5) and the surfaces (b) of the depression (3) opposite thereto.
Patent AU-5883780-A (AU)
Title: Swivel base for vice
Inventor: BUNYEA R F
IPC: B25B1/22
Filed: 1980-05-28
Abstract: A vise having jaw gripping members supported by a body having a bowl shaped body member is described. The body member is positioned in a cavity of a base member and a means is provided including a lock body positioned within the bowl member for selectively restraining the support body at a plurality of different orientations.
Patent AU-5935394-A (AU)
Title: Purification of polysaccharides
Inventor: EDEN JAMES
IPC: A23L5/20
Filed: 1994-04-11
Abstract: A steam-stripping process suitable for the removal of impurities from polysaccharides, including soluble starch hydrolysates, is disclosed herein. This process may be used in combination with other purification processes, such as ultrafiltration, ion exchange processes or treatment with activated carbon, as well as with a bleaching process. Soluble starch hydrolysates may also be purified by a combination of ultrafiltration and bleaching or by a combination of activated carbon treatment and bleaching. In these processes, the polysaccharide or the soluble starch hydrolysate that is produced is bland in flavor, free of off-odor, optionally, lighter or white in color and suitable for use in food systems requiring these characteristics. Other purification process combinations which are disclosed for removal of undesirable flavors, odors and colors from polysaccharides include:     1. Ultrafiltration and carbon treatment;   2. Ultrafiltration and steam-stripping;   3. Steam-stripping and carbon treatment;   4. Ion exchange treatment and ultrafiltration;   5. Ion exchange treatment and steam-stripping; and   6. Ion exchange treatment and carbon treatment.   A bleaching process may precede any of these processes. If ozone or a peroxide is employed, the bleaching step may follow any of these processes. Any of the processes may be combined with other processes disclosed herein to provide additional purification measures. The processes are particularly useful for purification of low molecular weight soluble polysaccharide hydrolysates, such as dextrins. These purified polysaccharides are used to improve foods and pharmaceutical products.
Patent AU-5992101-A (AU)
Title: Lock cap anchor assembly for orthopaedic fixation
Inventor: BONO FRANK SCOTT
IPC: A61B17/58
Filed: 2001-08-16
Abstract: An assembly such as an anchor screw, bone plate, offset hook, post, transverse connector or other spinal anchor for anchoring to bone and clamping a linkage such as a rod, wire cable or the like. The assembly has a top member with an open slot to receive the linkage, and a twist-lock closure cap to close the open end, capturing the linkage in the slot. One closure cap fits over and around the top member, with a set of segmented protrusions that extend through a corresponding set of protruding flange segments spaced about the circumference of the top member. The cap is configured to rotate and lock against the top member like a flange-locking bayonet mount when turned through a limited degree of rotation. Slots may be provided through the face of the closure cap allowing reduction tabs to project through the cap, and the locking cap may be adapted to a range of screw, eye, hook, post, connector and other anchor assemblies to securely clamp the linkage by use of a rotation tool disposed along an access path aligned with the axis of the screw, thus requiring no lateral clearance along the longitudinal direction of the linkage element. Locking is effected by a set screw that passes through the cap and tightens against the linkage to firmly immobilize it in the anchor assembly. Another cap embodiment fits into the center of the head with a partial twist locking motion. Opposed locking surfaces prevent slippage in the radial direction, and a sloping contact floor surface may apply torque to further increase pressure on urge mating detent features in an adjacent wall.
Patent AU-6050880-A (AU)
Title: Stabilizers for chlorinated thermoplast
Inventor: WIRTH H O
IPC: C08L27/04
Filed: 1980-06-23
Abstract: Chlorine-containing thermoplastics, containing a pyrrole of the formula I   <IMAGE> (I)  in which R1 is hydrogen, alkyl, cycloalkyl, aryl, alkoxycarbonylmethyl, free or esterified  alpha -hydroxyalkyl, free or esterified  alpha -hydroxycycloalkylmethyl, free or esterified  alpha -hydroxyaralkyl, alkoxymethyl, alkylthiomethyl, aryloxymethyl, arylthiomethyl, cycloalkoxymethyl, cycloalkylthiomethyl, aralkoxymethyl, aralkylthiomethyl, alkoxy, alkylthio, cycloalkoxy, cycloalkylthio, aralkoxy, arylalkylthio, aryloxy, arylthio, halogen, mercapto, mercaptomethyl or hydroxyl, R2 is hydrogen, alkyl, cycloalkyl, aryl, free or esterified  alpha -hydroxyalkyl, in which the alkyl moiety together with R1 can be alkylene, or free or esterified  alpha -hydroxycycloalkylmethyl, free or esterified  alpha -hydroxyaralkyl, alkoxy, cycloalkoxy, aralkoxy, aryloxy, alkylthio, cycloalkylthio, aralkylthio, arylthio, alkoxymethyl, alkylthiomethyl, aryloxymethyl, arylthiomethyl, cycloalkoxymethyl, cycloalkylthiomethyl, aralkoxymethyl, aralkylthiomethyl, hydroxyl, cyano, free carboxyl or carboxyl in the form of a salt or an ester, or acyl, it being possible for acyl together with R1 to be -CO-alkylene, in which -CO- is bonded in the 3-position, or R2 is halogen, mercapto or mercaptomethyl, and R3 is alkyl, cycloalkyl, aralkyl, aryl, free or esterified hydroxymethyl, alkoxymethyl, alkylthiomethyl, cycloalkoxymethyl, cycloalkylthiomethyl, aralkoxymethyl, arylalkylthiomethyl, aryloxymethyl or arylthiomethyl, alkoxy, alkylthio, cycloalkoxy, cycloalkylthio, aralkoxy, aralkylthio, aryloxy, arylthio, halogen, mercapto or mercaptomethyl, or if R2 is carboxyl in the form of a salt, R3 is hydrogen and R1 is as defined, or in which R3 is hydroxyl and R1 is hydrogen, alkyl or aryl and R2 is hydrogen, alkyl, aryl or acyl, or a salt thereof.
Patent AU-6165294-A (AU)
Title: Recombinant virus immunotherapy
Inventor: PAOLETTI ENZO
IPC: A61K35/76
Filed: 1994-01-21
Abstract: Attenuated vaccinia or canarypox recombinant viruses containing DNA coding for a cytokine and/or a tumor associated antigen, as well as methods and compositions employing the viruses, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The DNA can code for at least one of: human tumor necrosis factor; nuclear phosphoprotein p53, wildtype or mutant; human melanoma-associated antigen; IL-2; IFN gamma ; IL-4; GMCSF; IL-12; B7; erb-B-2 and carcinoembryonic antigen. The recombinant viruses and gene products therefrom are useful for cancer therapy.
Patent AU-6193096-A (AU)
Title: Medical connector
Inventor: LOPEZ GEORGE A
IPC: A61M39/14
Filed: 1996-08-07
Abstract: A safety connector is provided for connection to the branch port on a fluid flow line. The connector comprises a tubular body having an opening at its distal end to receive a branch port and a channel in the wall of the tubular body adjacent to the distal end. The channel is adapted to receive the fluid flow line when the branch port is engaged within the tubular body. The connector also comprises a locking rotatable collar located on the distal end of the tubular body. The collar is rotatable from a first position wherein the channel is adapted to receive the fluid flow line when the branch port is engaged within the tubular body, and a second position wherein the collar prevents the removal of the branch port from the tubular body.
Patent AU-6238498-A (AU)
Title: Biocompatible compounds for pharmaceutical drug delivery systems
Inventor: STEFELY JAMES S
IPC: A61K47/34
Filed: 1998-02-04
Abstract: The invention relates to a sustained release medicinal formulation suitable for nasal and/or oral inhalation comprising: 
(a) a propellant which comprises a hydrofluorocarbon; 
(b) a therapeutically effective amount of a drug dispersed in the formulation as a micronized suspension; and 
(c) a sufficient amount of a biocompatible polymer substantially completely dissolved in the formulation so as to provide for sustained release of the drug;  
wherein the sustained release formulation results in discrete, nonfilm forming particles upon delivery, the biocompatible polymer is present in at least about a 4:1 ratio by weight of biocompatible polymer to drug, and 
wherein the biocompatible polymer comprises at least one chain of units of the formula -[X-R 1 -C(O)]- wherein: 
(a) each R 1  is an independently selected organic group that links the X group to the carbonyl group; and 
(b) each X is independently oxygen, sulfur, or catenary nitrogen.  Furthermore, a metered dose inhaler containing the sustained release medicinal formulation is disclosed.
Patent AU-6301486-A (AU)
Title: Coder for multi-dimensional difference pcm
Inventor: GRALLERT HANS-JOACHIM
IPC: H03M3/04
Filed: 1986-09-22
Abstract: 1. Multidimensional DPCM coder, the input (1) of which is supplied with digitized samples (si ) from which, by forming the difference within each case one estimated value (si ), DPCM signal values (DELTA si ) are calculated which are supplied to a quantizing device (QE) at the output (3) of which quantized DPCM values (DELTA si,q ) are output, characterized by : a) a series circuit of four subtracting units (SU1, SU2, SU3, SU4) which is inserted between the input (1) of the coder and the input (2) of the quantizing device (QE), b) a first computing loop, which is connected from the output (3) of the quantizing device (QE) via a first multiplier (M1), which multiplies the input signal by a constant prediction factor (a), back to the subtraction input (-) of a fourth one of the subtracting units (SU4) preceding the quantizing devices, c) a second computing loop, which is connected from the output (3) of the quantizing device (QE) via the first multiplier (M1) and via a second multiplier (M2), which also multiplies by the prediction factor (a), back to the subtraction input (-) of the third subtracting unit (SU3) preceding the fourth subtracting unit (SU4), d) a third computing loop, which is connected from the output of the quantizing device (QE) via a first adder (AD1), a second register (R2) and via at least one multiplier (M3, M4), multiplying by the third power of the prediction factor (a), back to the subtraction input (-) of a second subtracting unit (SU2) preceding the third subtracting unit (SU3), in which arrangement the third computing loop e) contains an inner computing loop which exhibits the first adder (AD1) connected to the output (3) of the quantizing device, the output of which is connected via a series circuit of the second register (R2) and a third multiplier (M3) multiplying by the prediction factor (a) and via a second adder (AD2) back to the second input of the first adder (AD1), f) a fourth computing loop which is connected via the first adder (AD1) and a line predictor (PRL) which outputs an additional estimated value (szi+1 , szi+2 ) at an output (8, 9), back to the subtraction input of a first subtracting unit (SU1) which precedes the second subtracting unit (SU2) and in which a further output (6) of the line predictor (PRL) is connected to the second input of the second adder (AD2).
Patent AU-6322086-A (AU)
Title: Method and apparatus for dynamic signature verification
Inventor: ASBO EINAR L
IPC: G07C9/00
Filed: 1986-09-29
Abstract: Orthogonal output signals generated by a stylus (40), are normalized such that they are insensitive to the rotational position of the stylus (40) with respect to the writer's grip. Pressure measurements made by strain gauges (52) on a flexible diaphragm (50) in the stylus (40) are sampled at discrete intervals and a normalization angle of writing movement is calculated, representative of the average direction of the signature, by a processor (60). Each sample of orthogonal output signals is then assigned a vector length which is rotated by the normalization angle. The normalized samples are utilized to perform signature analysis by a comparison with a stored reference signature set of normalized orthoganal samples carried out by the processor (60).
Patent AU-6435294-A (AU)
Title: Expression of beta-2-microglobulin in pichia pastoris
Inventor: HUNTER MICHAEL GEORGE
IPC: C07K14/115
Filed: 1994-04-08
Abstract: A hybrid fusion protein comprising a first antigenic amino acid sequence fused to a second amino acid sequence substantially homologous to B2M or a fragment thereof.
Patent AU-6490994-A (AU)
Title: Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
Inventor: FOWLKES DANA MERRIMAN
IPC: C12P21/02
Filed: 1994-03-23
Abstract: Yeast cells are engineered to express both a surrogate of a pheromone system protein (e.g., enzymes involved in maturaton of  alpha -factor, transporters of a-factor, pheromone receptors, etc.) and a potential peptide modulator of the surrogate, in such a manner that the inhibition or activation of the surrogate affects a screenable or selectable trait of the yeast cells. Various additional features improve the signal-to-noise ratio of the screening/selection system. <IMAGE>
Patent AU-6493399-A (AU)
Title: Horizontal reference marker
Inventor: BRYFORS UNO
IPC: B66C13/48
Filed: 1999-09-29
Abstract: A horizontal reference marker and method of using the horizontal reference marker to determine the exact position on the ground of a ground slot for a standard freight container. At least two horizontal reference markers are fixed to the ground or any substantially horizontal stacking surface and arranged in a known position relative to a ground slot on the ground. The horizontal reference markers are shaped suitable for detection by laser means mounted on container cranes. The advantage is precise and parallel positioning of a container placed on the ground, which ensures that container stacks have sufficient clearance between them and simplifies container handling.
Patent AU-6810090-A (AU)
Title: Improvements to tyre and wheel rim assemblies
IPC: B60C15/02
Filed: 1990-12-17
Abstract: A tyre and wheel rim assembly for a vehicle, the tyre (1) comprising a pair of bead regions each reinforced by a bead core (5) and the wheel rim (2) comprising a pair of bead seats (6,7) characterised by one bead region of the tyre having an additional retention zone (18) positioned axially inwards of and integral with the main bead region, the retention zone (18) having an axially inner tip or toe (21) substantially inwards of the main bead region and the construction of the bead between the bead core (5) and tip (21) providing substantial resistance to compressive forces therebetween, and the wheel rim (2) comprises axially inwards of and adjacent to one of the bead seats (6,7), which is that part of the bead seat contacted by a standard tyre, a circumferentially extending toot (21) having a sharp edge inter-engaging only the retention zone (18) of the tyre at the tip (21) such that when lateral force is applied to the tyre tread and internal inflation pressure is low, axially inward movement of the tip (21) is resisted by tip-to-tooth inter-engagement thus causing bead rotation about the tip (21) and generation of compression force in those parts of the bead region between the tip (21) and the core (5) to provide bead retention at the bead seat. The invention also provides a wheel rim and a tyre having the above features. <IMAGE>   <IMAGE>
Patent AU-6914991-A (AU)
Title: Solubilization of t-pa
Inventor: KOHNERT ULRICH DR
IPC: A61K47/18
Filed: 1990-12-19
Abstract: The invention relates to a pharmaceutical preparation of a protein with t-PA activity, with an enzymatic activity of at least 0.25 MU/ml and a pH of 4.5 to 9, containing a substance from the group citric acid, ascorbic acid, 2-oxoglutaric acid, fumaric acid, tris and EDTA in a concentration of at least 0.2 mol/l, and to a drug based on a protein with t-PA activity and a process for producing it.
Patent AU-6933394-A (AU)
Title: Vaccine containing a serine protease
Inventor: DALTON JOHN PIUS
IPC: C12N9/50
Filed: 1994-06-14
Abstract: PCT No. PCT/GB94/01274 Sec. 371 Date Apr. 26, 1996 Sec. 102(e) Date Apr. 26, 1996 PCT Filed Jun. 14, 1994 PCT Pub. No. WO94/28925 PCT Pub. Date Dec. 22, 1994Disclosed is the invention relates to the use of serine protease having peptidyl peptidase activity in the formulation of vaccines for combating helminth parasites. The protease is derived from a fluke Fasciola hepatica.
Patent AU-7024494-A (AU)
Title: Plasmid derived from Lactobacillus delbrueckii sp
Inventor: MOLLET BEAT
IPC: C12N15/74
Filed: 1994-08-12
Abstract: The present invention concerns a plasmid derived from Lactobacillus delbrueckii sp. comprising at least the restriction map of the Figure 1 or portion(s) thereof; the recombinant vector comprising the said plasmid, at least one DNA sequence capable of replication into E. coli and/or Lc. lactis and at least one marker. The present invention concerns also the microorganism transformed by the said plasmid and/or by the said recombinant vector. <IMAGE>
Patent AU-7057796-A (AU)
Title: Media pipeline system
Inventor: PETERS ERIC C
IPC: H04N7/52
Filed: 1996-11-01
Abstract: The invention is a data pipeline system which synchronizes the display of digitized audio and video data regardless of the speed at which the data was recorded on its linear medium. To do this, the video data is played at a constant speed, synchronized by the audio speed. Further, the invention uses a method of "staging" data in storage buffers, i.e, ring buffers, which encourages efficient use of the viewer module resources by not permitting the viewer to read excessive amounts of data at any one time, i.e., to read only enough data into any one ring buffer so that the amount of data in the ring buffer is roughly equivalent to the amount of data in the other ring buffers and yet permitting the viewer to read large enough chunks of data to promote efficient use of the fill system. <IMAGE>
Patent AU-7475391-A (AU)
Title: Improvements in and relating to magnetic resonance imaging
Inventor: KUCHARCZYK JOHN
IPC: G01R33/563
Filed: 1991-03-06
Abstract: The invention provides a method of monitoring the vasodilatory or vasoconstrictive effects of a physiologically active substance administered to a human or non-human animal body, said method comprising the steps of: administering said substance into said body; administering into the systemic vasculature of said body a contrast enhancing amount of an intravascular paramagnetic metal containing magnetic resonance imaging contrast agent; subjecting said body to a magnetic resonance imaging procedure capable of generating from magnetic resonance signals from said body a series of temporally spaced images of at least a part of said body into which said agent passes, said procedure being a fast imaging procedure having an image acquisition time of less than five seconds; and detecting temporal variations in said signals or images whereby to monitor the vasoconstriction or vasodilation induced by said substance.
Patent AU-7513296-A (AU)
Title: Capacitive thin films using diamond-like nanocomposite materials
Inventor: GOEL ARVIND
IPC: H01G4/08
Filed: 1996-09-25
Abstract: A method of making capacitors comprising, providing as the dielectric and/or conductive layers, a material made from a diamond-like nanocomposite solid-state material having interpenetrating atomic scale networks of carbon in a diamond-like carbon network stabilized by hydrogen, a glass-like silicon network stabilized by oxygen, and optionally at least one additional network of dopant elements or dopant compounds having elements from Groups 1-7b and 8 of the periodic table.
Patent AU-7561694-A (AU)
Title: Aqueous multiple-phase isolation of polypeptide
Inventor: BUILDER STUART
IPC: C07K14/47
Filed: 1994-08-10
Abstract: A method is described for isolating an exogenous polypeptide in a non-native conformation from cells, such as an aqueous fermentation broth, in which it is prepared comprising contacting the polypeptide with a chaotropic agent and preferably a reducing agent and with phase-forming species to form multiple aqueous phases, with one of the phases being enriched in the polypeptide and depleted in the biomass solids and nucleic acids originating from the cells. Preferably, the method results in two aqueous phases, with the upper phase being enriched in the polypeptide.
Patent AU-7580591-A (AU)
Title: Reversed phase chromatographic process
Inventor: DORAN NARCISCO O
IPC: C07C237/46
Filed: 1991-02-21
Abstract: An improved process for the reversed phase chromatographic decolorization, separation, and purification of water-soluble, nonionic contrast media compounds from solutions containing nonionic compound impurities involves the steps of (a) packing a chromatographic column with a chromatographic packing material; (b) passing through the column a solution containing a water-soluble, nonionic contrast media compound and nonionic compounds as impurities at a loading ratio between approximately 10 to 1 and 1.5 to 1 wt. packing material/total wt. nonionic compounds; and (c) eluting the column to produce an eluate containing substantially pure, water-soluble, nonionic contrast media compound or MRI agent. The process can be economically practiced on a factory scale and efficiently removes non-polar impurities difficult to remove by conventional methods.
Patent AU-7643494-A (AU)
Title: Process for microaperturing and microembossing a polymeric web
Inventor: DOBRIN GEORGE CHRISTOPHER
IPC: A61F13/514
Filed: 1994-09-06
Abstract: A continuous, multi-phase process for microaperturing and microembossing a substantially continuous web of substantially planar polymeric film to conform with the image of multiple forming structures, each having a patterned forming surface with a multiplicity of fine-scale apertures and an opposed surface. Each forming structure is open from the apertures in the forming surface to its opposed surface. The web of film has an indefinite length, a first surface, a second surface and a thickness. The thickness is the distance between the first surface and the second surface. The process includes at least two sequential forming phases, one of which involves aperturing of the web of film to coincide with fine-scale apertures in the first forming structure and another of which involves conformance of the web of film to the profile of the fine-scale apertures in the second forming structure.